Fearless Solutions (Best Invest)’s AbbVie ABBV Stock Holding History

Fearless Solutions (Best Invest)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.16M	Sell	12,568 -253	-2%	-$54.4K	1.67%	19
2026 Q1	$2.79M	Sell	12,821 -214	-2%	-$47.5K	1.68%	17
2025 Q4	$2.98M	Sell	13,035 -71	-0.5%	-$16.2K	1.8%	18
2025 Q3	$3.03M	Sell	13,106 -2	-0%	-$407	1.95%	16
2025 Q2	$2.43M	Sell	13,108 -122	-0.9%	-$22.7K	1.7%	16
2025 Q1	$2.77M	Sell	13,230 -255	-2%	-$49.6K	2.15%	14
2024 Q4	$2.4M	Buy	+13,485	New	+$2.48M	1.83%	15

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Fearless Solutions (Best Invest)'s ABBV Position: Q2 2026 in Review

Fearless Solutions (Best Invest) reduced its AbbVie (ABBV) stake by 2% in Q2 2026, selling an estimated $54.4K and leaving 12,568 shares worth $3.16M. The position accounts for 1.67% of the portfolio, ranked #19.

Fearless Solutions (Best Invest) first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 2,841 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Fearless Solutions (Best Invest) held 12,568 shares of AbbVie worth $3.16M as of Q2 2026.
Fearless Solutions (Best Invest) sold 253 AbbVie shares in Q2 2026, an estimated $54.4K.
AbbVie made up 1.67% of Fearless Solutions (Best Invest)'s portfolio in Q2 2026, its #19 holding.
Fearless Solutions (Best Invest) first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
2,841 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fearless Solutions (Best Invest)'s 13F filing for Q2 2026, filed 22 Jul 2026.